4 completed, 1 terminated. 5 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 4, Terminated 1 |
Follow amprenavir: new trials by email Literature Review of amprenavir trials Research Report on amprenavir
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Once-Daily Drug Regimen for HIV-Infected Patients Amprenavir, Ritonavir, Abacavir - Acquired Immunodeficiency Syndrome, HIV Infections | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 25 | 2000-01-01 | 2008-03-04 |
| Investigation of the Potential Pharmacokinetic Interaction Between Nevirapine, Abacavir and Amprenavir in HIV-1 Infected Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Naive Adults Nevirapine, Amprenavir, Abacavir - HIV Infections | Phase 1 | Terminated | Boehringer Ingelheim | 8 | 1999-04-01 | 2014-07-14 |
| Drug Interactions Among Anti-HIV Agents Amprenavir, Efavirenz, Abacavir, Nelfinavir, Ritonavir - HIV Infection | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 22 | 1998-08-01 | 2008-03-04 |
| A Study of 141W94 in Combination With Other Anti-HIV Drugs Indinavir sulfate, Amprenavir, Nelfinavir mesylate - HIV Infections | Phase 1 | Completed | Glaxo Wellcome | 48 | 2005-06-24 | |
| A Phase I Trial to Evaluate the Safety, Pharmacokinetics and Antiviral Activity of 141W94 After Multiple Dosing in Patients With HIV Infection Abacavir sulfate, Amprenavir, Lamivudine - HIV Infections | Phase 1 | Completed | Glaxo Wellcome | 60 | 2005-06-24 |
HIV Infections (5) · Acquired Immunodeficiency Syndrome (1)
Glaxo Wellcome (2) · National Institute of Allergy and Infectious Diseases (NIAID) (2) · Boehringer Ingelheim (1)
United States (4)